https://www.businesswire.com/news/home/20260427621232/en/PlaqueTec-Closes-%245-Million-Financing
PlaqueTec Closes $5 Million Financing
PlaqueTec, a medtech company pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease (CVD), today announced it has ...
closesmillionfinancing
https://www.plaquetec.com/
Plaquetec | Endotyping Coronary Artery Disease
PlaqueTec is pioneering the development of biomarker-based, cardiovascular personalised medicine strategies, using its novel Liquid Biopsy System, to transform...
coronary arterydisease